NEW DELHI — The World Health Organization granted an emergency use license Nov. 3 to a coronavirus vaccine developed in India, offering reassurance for a shot the country’s regulators allowed long before advanced safety and efficacy testing was completed.
Coronavirus
Associated Press: WHO authorizes Covaxin, an Indian-made COVID vaccine
A health worker displays a vial of the Covaxin vaccine against the Covid-19 coronavirus at a health centre in New Delhi on July 15, 2021.
